Ovid Therapeutics Files 2024 Annual Report Amendment
Ticker: OVID · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 1636651
| Field | Detail |
|---|---|
| Company | Ovid Therapeutics Inc. (OVID) |
| Form Type | 10-K/A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, sec-filing
TL;DR
Ovid Therapeutics filed an amendment to its 2024 10-K on 4/30/25.
AI Summary
Ovid Therapeutics Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. This amendment, filed on April 30, 2025, provides updated information for the SEC. The company, headquartered in New York, operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides updated financial and operational information for Ovid Therapeutics Inc., which is crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a routine amendment to an annual report, not indicating new or elevated risks.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 001-38085 — Commission File Number (Identifies the company's filings with the SEC.)
Key Players & Entities
- Ovid Therapeutics Inc. (company) — Registrant
- 2024 (date) — Fiscal Year End
- April 30, 2025 (date) — Filing Date
- New York (location) — Business Address City
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What is the purpose of this 10-K/A filing?
This filing is an amendment (Amendment No. 1) to the annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024.
When was this amendment filed with the SEC?
This amendment was filed on April 30, 2025.
What is the exact name of the company filing this report?
The exact name of the Registrant is Ovid Therapeutics Inc.
What is Ovid Therapeutics Inc.'s Standard Industrial Classification code?
Ovid Therapeutics Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Ovid Therapeutics Inc. headquartered?
Ovid Therapeutics Inc.'s business address is located at 441 Ninth Avenue, 14th Floor, New York, NY 10001.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding Ovid Therapeutics Inc. (OVID).